Direxion Daily BA Bear 1X Shares (NASDAQ: BOED)

最新ニュース Direxion Daily BA Bear 1X Shares (NASDAQ:BOED)

The Fund, under normal circumstances, invests at least 80 percent of the Funds net assets (plus borrowings for investment purposes) in financial instruments, including swap agreements and options, that, in combination, provide 1X daily inverse (opposite) or short exposure to BA, consistent with the Funds investment objective.

Dreyfus Govt Cash Man Ins

Gs Financial Square Treasury Instruments Fund

Direxion Daily BA Bear 1X Shares

Shares of Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) rose sharply in today's pre-market trading as the company reported stronger-than-expected second-quarter financial results and <a href="https://www.benzinga.com/markets/earnings/25/07/46356144/levi-strauss-shares-jump-on-q2-earnings-revenue-beat-raised-outlook">raised its full-year guidance</a>.
The company reported second-quarter revenue of $1.45 billion, beating analyst estimates of $1.37 billion. The company reported second-quarter adjusted earnings of $0.22 per share, beating estimates of $0.13 per share, according to Benzinga Pro.
Levi Strauss shares jumped 7.9% to $21.30 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>Future FinTech Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTFT#NASDAQ">FTFT</a>) surged 125.2% to $3.40 in pre-market trading after gaining 9% on Thursday.</li>
<li>Above Food Ingredients Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABVE#NASDAQ">ABVE</a>) climbed 104.4% to $3.17 in pre-market trading after jumping 335% on Thursday.</li>
<li>LM Funding America, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMFA#NASDAQ">LMFA</a>) rose 83.1% to $4.31 in pre-market trading after gaining 8% on Thursday.</li>
<li>Bit Origin Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOG#NASDAQ">BTOG</a>) jumped 58.4% to $0.4594 in pre-market trading as Bitcoin rallied past $118,000.</li>
<li>ATIF Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAI#NASDAQ">ZBAI</a>) gained 29% to $0.5041 in pre-market trading after adding 9% on Thursday.</li>
<li>TAO Synergies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TAOX#NASDAQ">TAOX</a>) gained 17% to $9.33 in pre-market trading after gaining 12% on Thursday.</li>
<li>Argo Blockchain plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBK#NASDAQ">ARBK</a>) gained 22.4% to $0.3392 in pre-market trading after adding 4% on Thursday.</li>
<li>Alterity Therapeutics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) gained 17.5% to $4.57 in pre-market trading.</li>
<li>Cango Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CANG#NYSE">CANG</a>) gained 17.1% to $6.30 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>Capricor Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) declined 44% to $6.39 in pre-market trading after the company issued regulatory update on Deramiocel BLA for Duchenne Muscular Dystrophy.</li>
<li>Concorde International Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIGL#NASDAQ">CIGL</a>) dipped 30% to $4.00 in pre-market trading after dipping 80% on Thursday.</li>
<li>Q32 Bio Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QTTB#NASDAQ">QTTB</a>) dipped 24.7% to $2.50 in pre-market trading after gaining 120% on Thursday.</li>
<li>Youlife Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YOUL#NASDAQ">YOUL</a>) fell 23.2% to $3.84 in pre-market trading after dipping 82% on Thursday.</li>
<li>Pop Culture Group Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPOP#NASDAQ">CPOP</a>) fell 22.2% to $0.7003 in pre-market trading after gaining over 29% on Thursday. The company recently completed a private placement, raising $30.5 million.</li>
<li>SU Group Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUGP#NASDAQ">SUGP</a>) fell 18.1% to $1.27 in pre-market trading after gaining 27% on Thursday.</li>
<li>Australian Oilseeds Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COOT#NASDAQ">COOT</a>) declined 17% to $0.5000 in pre-market trading.</li>
<li>Steakholder Foods Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKH#NASDAQ">STKH</a>) shares tumbled 13.3% to $2.60 in pre-market trading after jumping 71% on Thursday.</li>
<li>Resolute Holdings Management, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RHLD#NASDAQ">RHLD</a>) shares fell 9.5% to $36.01 in pre-market trading after gaining over 3% on Thursday.</li>
<li>Albemarle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) fell 4% to $71.67 in pre-market trading after gaining 5% on Thursday.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46361010/johnson-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts-2">Johnson &amp; Johnson Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>
Photo via Shutterstock

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ABVE

ARBK

Alterity Therapeutics Limited - American Depositary Shares

ATHE

BTOG

CANG

CAPR

CIGL

COOT

CPOP

FTFT

LEVI

LMFA

QTTB

RHLD

STKH

SUGP

TAOX

YOUL

ZBAI

Why Levi Strauss Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket

WIIM

PFGC

Performance Food Group shares are trading higher after Bloomberg reported the company is said to have drawn takeover interest from US Foods.

Canaccord Genuity analyst George Gianarikas maintains MP Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) with a Buy and raises the price target from $27 to $55.

Price Target

Analyst Ratings

Canaccord Genuity Maintains Buy on MP Materials, Raises Price Target to $55

AVAV

KTOS

RCAT

UAVS

UMAC

Shares of drone stocks are trading higher after Secretary of Defense Pete Hegseth announced efforts to fast-track drone production.

The Trump administration has announced that undocumented immigrants will no longer be eligible for various federal programs.
What Happened: The Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., revealed on Thursday that immigrants residing in the U.S. illegally will be barred from accessing the Head Start program and several other federal benefits and programs.
&#8220;Head Start is among the programs included in the updated and expanded list of classified "Federal public benefits" under PRWORA to ensure enrollment in Head Start is reserved for American citizens from now on,&#8221; stated the official statement.
The impacted programs, such as homelessness assistance, Title X family planning, substance abuse treatment, and mental health services—generally base eligibility on income and other verification criteria rather than immigration status.
Furthermore, the Department of Education (DOE) has announced that undocumented immigrants will no longer be eligible for taxpayer-funded benefits for postsecondary education programs. This move comes after the repeal of a former President Bill Clinton-era &#8220;Dear Colleague&#8221; letter that had permitted certain undocumented individuals to receive federal public benefits.
Secretary of Education&nbsp;Linda McMahon&nbsp;stated, &#8220;Postsecondary&nbsp;education programs funded by the&nbsp;federal government should benefit American&nbsp;citizens, not illegal aliens.&#8221;
See Also:&nbsp;<a href="https://benzinga.com/crypto/cryptocurrency/25/07/46348529/xrp-breaks-above-2-40-for-first-time-since-may-how-high-can-it-go" target="_blank" rel="noreferrer noopener">XRP Breaks Above $2.40 For First Time Since May: How High Can It Go?</a>
Why It Matters: The Trump administration&#8217;s move to restrict federal benefits for undocumented immigrants comes amid a series of policy changes. These changes have sparked a debate on the administration&#8217;s approach to immigration and its impact on various sectors.
The administration&#8217;s aggressive immigration policy, backed by a $45 billion budget, has&nbsp;<a href="https://www.benzinga.com/news/politics/25/07/46284121/trumps-45-billion-immigration-policy-supercharges-profits-for-private-prisons-under-big-beautiful-bill">boosted profits</a>&nbsp;for private prisons, while also drawing criticism from some quarters.
Meanwhile, former Secretary of State&nbsp;John Kerry&nbsp;recently&nbsp;<a href="https://www.benzinga.com/news/politics/25/07/46360480/john-kerry-says-trump-was-right-about-the-border-and-it-was-joe-biden-that-missed-on-immigration-issue">acknowledged</a>&nbsp;that the Democratic party had &#8220;missed&#8221; on the issue of immigration, conceding that &#8220;Trump was right&#8221; about the need for strict enforcement of immigration laws.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46257635/trump-administrations-ice-raids-compared-with-wwii-japanese-internment-camps-by-george-takei-politicians-lie-and-people-believe-that-lie">Trump Administration&#8217;s ICE Raids Compared With WWII Japanese Internment Camps By George Takei: &#8216;Politicians Lie, And People Believe That Lie&#8217;</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Education

Trump Ends Head Start Program For 'Illegal Aliens,' Moves To Cut Clinton-Era Postsecondary Aid And Other Federal Benefits

VBIX

Viewbix Subsidiary Metagramm Launches AI-Powered On-Premise Grammar Engine For Enterprises Prioritizing Data Privacy And Customization

Biotech

General

INKT

MiNK Therapeutics shares are trading higher after the company announced a publication in Oncogene.

ZVRA

Zevra Showcases MIPLYFFA Data At NNPDF Conference; Highlights Long-Term Efficacy, Mechanism In Treating Niemann-Pick Type C

BriaCell Therapeutics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCTX#NASDAQ">BCTX</a>, BCTXW, BCTXZ))) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BCT#TSX">BCT</a>) ("BriaCell" or the "Company"), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced updated Phase 2 survival data for its lead immunotherapy candidate, Bria-IMT, in combination with an immune check point inhibitor (CPI).
The data show a meaningful survival advantage in heavily pretreated metastatic breast cancer (MBC) patient subtypes:
<ul>
<li>Triple negative breast cancer (TNBC): median overall survival (OS) of 13.9 months vs. 11.8 months for antibody drug conjugate Trodelvy (sacituzumab govitecan-hziy) and 6.9 months single agent chemotherapy data. BriaCell's median OS has improved from 11.4 months last <a href="https://feeds.issuerdirect.com/news-release.html?newsid=8470896771035848&amp;symbol=BCTX">reported at ASCO in June 2025</a>.1</li>
<li>Hormone receptor positive (HR+): median overall survival (OS) of 17.3 months vs. 14.4 months for Trodelvy and 11.2 months in single agent chemotherapy data.</li>
</ul>

BCTX

TSX:BCT

BriaCell Therapeutics Announces Updated Phase 2 Survival Data For Immunotherapy Candidate, Bria-IMT, In Combination With Immune Check Point Inhibitor

<a href="https://www.nature.com/articles/s41388-025-03491-0" title="https://www.nature.com/articles/s41388-025-03491-0">https://www.nature.com/articles/s41388-025-03491-0</a>

MiNK Therapeutics Announces Publication In Oncogene Titled 'Salvage therapy with allogeneic invariant natural killer cells in a heavily pre-treated germ cell tumor'

Canaccord Genuity analyst Susan Anderson downgrades Helen Of Troy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) from Buy to Hold and lowers the price target from $47 to $26.

Downgrades

HELE

Canaccord Genuity Downgrades Helen Of Troy to Hold, Lowers Price Target to $26

Canaccord Genuity analyst Yuri Lynk downgrades North American Const Gr (TSX:<a class="ticker" href="https://www.benzinga.com/stock/NOA#TSX">NOA</a>) from Buy to Hold and lowers the price target from C$33 to C$24.5.

TSX:NOA

Canaccord Genuity Downgrades North American Const Gr to Hold, Lowers Price Target to C$24.5

MTY Food Gr (TSX:<a class="ticker" href="https://www.benzinga.com/stock/MTY#TSX">MTY</a>) reported quarterly earnings of $1.17 per share which missed the analyst consensus estimate of $1.21 by 3.31 percent. This is a 6.4 percent decrease over earnings of $1.25 per share from the same period last year. The company reported quarterly sales of $304.874 million which missed the analyst consensus estimate of $306.468 million by 0.52 percent. This is a 0.37 percent increase over sales of $303.739 million the same period last year.

Earnings

Earnings Misses

TSX:MTY

MTY Food Gr Q2 Adj. EPS $1.17 Misses $1.21 Estimate, Sales $304.874M Miss $306.468M Estimate

Nissan Motor (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NSANY#OTC">NSANY</a>) has reportedly opened negotiations with Honda Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMC#NYSE">HMC</a>) to produce vehicles for its rival at a U.S. factory. Both companies seek ways to blunt the impact of upcoming U.S. tariffs on Japanese-made autos.
According to <a href="https://asia.nikkei.com/Business/Automobiles/Nissan-mulls-making-trucks-for-Honda-at-underused-US-plant" target="_blank" rel="noreferrer noopener">Nikkei Asia</a>, the companies are exploring a supply arrangement that could see Nissan manufacture large pickup trucks for Honda at its Canton, Mississippi, plant. 
The vehicles would bear Honda nameplates and be sold under the Honda brand in the U.S. market. This would allow Honda to expand its presence in the full-size pickup segment, which currently makes up about 20% of new car sales in the U.S.
Also Read: <a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46338641/ray-dalio-says-trumps-tariffs-are-theoretical-warns-they-may-not-bring-manufacturing-back-to-us" target="_blank" rel="noreferrer noopener">Ray Dalio Says Trump&#8217;s Tariffs Are &#8216;Theoretical,&#8217; Warns They May Not Bring Manufacturing Back To US</a>
Nissan&#8217;s Canton plant is currently underused, operating at just 57% capacity in 2024. Producing vehicles for Honda could help increase utilization and improve Nissan&#8217;s financial position. The move would accelerate Honda&#8217;s local production without requiring significant investment in development.
Nikkie Asia mentioned that the plan comes as U.S. tariffs set to take effect August 1 are expected to reduce Honda&#8217;s operating profit by $4.42 billion and Nissan&#8217;s by $3.06 billion.
Nikkei Asia reports that the companies are ruling out a merger for now but are holding regular meetings to pursue mutually beneficial cooperation.
Separately, Nissan <a href="https://global.nissannews.com/en/releases/nissan-successfully-priced-its-bonds">raised</a> approximately 860 billion Japanese yen (~$5.86 billion) through oversubscribed U.S., euro, and yen bond offerings. The proceeds will support debt refinancing, general operations, and future investments in electrification and software-defined vehicles as part of its Re:Nissan recovery plan.
Price Action: HMC shares are trading lower by 0.33% to $30.65 premarket at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46362407/tesla-sales-slump-prompts-panasonic-to-delay-4-billion-us-battery-plant-expansion-report" target="_blank" rel="noreferrer noopener">Tesla Sales Slump Prompts Panasonic To Delay $4 Billion US Battery Plant Expansion: Report</a></li>
</ul>
Photo by JRomero04 via Shutterstock

Tech

Media

NSANY

Tariff Troubles Drive Nissan, Honda To U.S. Manufacturing Talks: Report

LEVI: 10% &#x7C; <a href="https://www.benzinga.com/node/46355261">Levi Strauss shares are trading higher after the company reported better-than-expected Q2 EPS and sales and raised its FY2025 Adj. EPS guidance.</a>
&nbsp;
RCAT: 20% &#x7C; <a href="https://www.benzinga.com/node/46356125">Shares of drone stocks are trading higher after Secretary of Defense Pete Hegseth announced efforts to fast-track drone production.</a>
&nbsp;
SGN: 229% &#x7C; <a href="https://www.benzinga.com/node/46362689">Signing Day Sports Says BlockchAIn Submits Draft Registration Statement On Form S-4 To SEC</a>

Market-Moving News for July 11th

Rosenblatt analyst Steve Frankel maintains Imax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IMAX#NYSE">IMAX</a>) with a Buy and maintains $35 price target.

IMAX

Rosenblatt Maintains Buy on Imax, Maintains $35 Price Target

Telsey Advisory Group analyst Dana Telsey maintains Levi Strauss (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) with a Outperform and raises the price target from $21 to $24.

Telsey Advisory Group Maintains Outperform on Levi Strauss, Raises Price Target to $24

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) has surged to a new all-time high of $118,909 on Coinbase on Friday morning propelled by steady institutional buying, but analysts warn the rally could face pressure from geopolitical and inflation-driven uncertainties in <a href="https://www.benzinga.com/money/bitcoin-price-prediction">the weeks ahead</a>.
What Happened: The world's largest cryptocurrency jumped 6.3% in the last 24 hours, breaking out of the sideways trading pattern that has persisted for much of the past two months.
Stephen Wundke, Director of Strategy and Revenue at Algoz, pointed to the continued inflows into U.S.-listed spot Bitcoin ETFs, amounting to $15 billion in net buying over the past two months, as a critical driver of upward momentum. 
"Institutions have kept buying BTC ETFs," Wundke told Benzinga. "Traders who lack exposure are now trying to recover positions, forcing prices higher."
He added that dovish inflation signals globally and renewed corporate interest in adding Bitcoin to treasury holdings are fostering favorable conditions for further upside. 
"History shows us when BTC breaks new highs and holds, there's been a circa 20% uplift in the next 60 days," he noted, predicting a short-term target of $125,000—provided inflation data from the U.S. remains benign.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46351536/you-can-stake-ethereum-solana-on-robinhood-but-is-it-worth-the-25-cut">You Can Stake Ethereum, Solana On Robinhood—But Is It Worth The 25% Cut?</a>
Ajay Dhingra, Head of Research and Partnerships at Unizen, was more cautious. "Bitcoin's new all-time high comes during a rare moment of calm in global politics and trade," he said. 
However, Dhingra warned that upcoming macro data releases—particularly GDP and inflation figures—may reflect the impact of Middle East tensions and impending tariffs, potentially reigniting market volatility. 
"This rally may not hold if that calm gives way to fresh volatility," he added.
The broader crypto market followed Bitcoin's lead. 
Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) rose over 8% to top $3,000, while XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) gained 8% as well to surpass $2.60.
Market sentiment also received a lift from optimism around likely ETF approvals for altcoins like Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) and Ripple, both of which broke key trendlines in recent trading sessions.
What&#8217;s Next: While enthusiasm is growing, experts caution that the sustainability of this rally hinges on upcoming macroeconomic events, particularly the U.S. inflation report due July 15 and the Bitcoin options expiry on July 25, two potential catalysts that could sway short-term market direction.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46345201/bitcoins-rally-to-112000-yes-its-different-this-time">Bitcoin&#8217;s Rally To $112,000: Yes, It&#8217;s Different This Time</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$SOL

$XRP

Bitcoin Sets All-Time High At $118,909, Ethereum, XRP Surge 8% Each

Wedbush analyst Michael Pachter upgrades AMC Entertainment Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) from Neutral to Outperform and raises the price target from $3 to $4.

Upgrades

Wedbush Upgrades AMC Entertainment Hldgs to Outperform, Raises Price Target to $4

<a href="https://www.globenewswire.com/Tracker?data=yvMhi_ChDD3chW5RQzQ2briyrR-S7enoDX01UG95JEdUuJ8u-ymmPLViG21v2fVkRKRmkw9FjkdL4NvexpvPqTP7eBjmN-wycV2vnGE0ORo=">Hyperscale Data, Inc.</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#NYSE">GPUS</a>), a diversified holding company ("Hyperscale Data" or the "Company"), today announced that its indirect, wholly owned subsidiary, Ault Markets, Inc. ("Ault Markets"), plans to launch <a href="https://www.globenewswire.com/Tracker?data=fNgjpo31Jqqllgsk6EdqNj1e_QUn6pc4k_g0N6gpg2DXPXPufqSlrO4-y2Ct0i-4ROHpPDxhYH72CLTSDrskDigNgV93vQx1NpGO47jyd0U=">StableShare</a> in the first quarter of 2026. StableShare is a next-generation platform for tokenizing public equities, private securities, real-world assets and structured finance products. The platform will be purpose-built for broker-dealers, institutional investors and other market participants seeking compliant access to digital assets backed by real-world value.

GPUS

Hyperscale Data's Ault Markets Plans To Launch StableShare In Q1 2026 For Tokenized Securities, Real Assets And Global Markets

Comments

Direxion Daily BA Bear 1X Shares

ニュース

最新ニュース Direxion Daily BA Bear 1X Shares (NASDAQ:BOED)

ニュース

パートナーシップ

ベンジンガ・グローバル